Try our Advanced Search for more refined results

Compulsory License Battle Moves To Indian Court

By Erin Marie Daly (March 13, 2008, 12:00 AM EDT) -- Heating up the controversy over compulsory licensing, the High Court of Delhi reportedly is set to consider whether Indian generics manufacturer Natco Pharma should be allowed to override patents on cancer drugs made by Pfizer Inc. and F. Hoffmann-La Roche Ltd....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!